Search results
4 paź 2024 · Metrics. Abstract. The concept of mRNA-based vaccines emerged more than three decades ago. Groundbreaking discoveries and technological advancements over the past 20 years have resolved the...
25 sie 2021 · We overview progress in developing mRNA vaccines for a wide range of infectious diseases such as influenza, Zika and respiratory syncytial virus (RSV), and discuss key issues facing the future...
1 lip 2024 · Nucleic acid technology has revolutionized vaccine development, enabling rapid design and production of RNA and DNA vaccines for prevention and treatment of diseases. The successful deployment of mRNA and plasmid DNA vaccines against COVID-19 has further validated the technology.
22 gru 2020 · Nucleic acid-based vaccines consist of either DNA or RNA encoding the target antigen, which potentially allows for the induction of both humoral and cellular immune responses once the encoded ...
23 gru 2020 · RNA vaccines encode the antigen of interest in messenger RNA (mRNA) or self-amplifying RNA (saRNA) – molecular templates used by cellular factories to produce proteins. Because of its transitory nature, there is zero risk of it integrating with our own genetic material.
4 sty 2023 · How proteins are made from vaccine DNA. Conclusion. Page last updated Wednesday, January 4, 2023. © Oxford Vaccine Group, The University of Oxford.
17 wrz 2020 · 1. DNA/RNA-based. DNA and RNA vaccines use fragments of genetic material made in the lab. These fragments code for a part of the virus (such as its spike protein). After the vaccine is...
